Multiple sclerosis associated amino acids of polymorphic regions relevant for the HLA antigen binding are confined to HLA-DR2

Human Immunology

Volumn 61, Issue 10, 2000, Pages 1021-1030

  Zipp, Frauke ^a,d   Windemuth, Christine ^b   Pankow, Harald ^c   Dichgans, Johannes ^d   Wienker, Thomas ^b   Martin, Roland ^f   Müller, Claudia ^e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d Department of Neurology ^*  (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Antigen binding; Autoimmunity; Genetic; HLA; Multiple sclerosis

Indexed keywords

ALANINE; AMINO ACID; ARGININE; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA DR1 ANTIGEN; HLA DR2 ANTIGEN; LYMPHOTOXIN; PROLINE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ANTIGEN BINDING; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENOTYPE; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RELAPSE;

ALLELES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR2 ANTIGEN; HUMANS; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC;

EID: 0033724959     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(00)00173-7     Document Type: Article

References (43)

1. Epidemiology and genetics of multiple sclerosis
2. The role of genetic factors in multiple sclerosis susceptibility
3. A full genome search in multiple sclerosis
4. Genetic predisposition to multiple sclerosis as revealed by immunoprinting
5. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group
6. Genetic factors in multiple sclerosis
7. HLA class II-associated genetic susceptibility in multiple sclerosis: A critical evaluation
8. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22
9. Multiple sclerosis in Northeast Scotland. An association with HLA-DQw1
10. HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis
11. Patients with multiple sclerosis carry DQB1 genes which encode shared polymorphic aminoacid sequences
12. An immunogenetic heterogeneity in multiple sclerosis
13. Primarily chronic progressive and relapsing/remitting multiple sclerosis: Two immunogenetically distinct disease entities
14. Vaccination with peptides from the MHC class II beta chain hypervariable region causes allele-specific suppression of EAE
15. A synthetic peptide from the third hypervariable region of major histocompatibility complex class II beta chain as a vaccine for treatment of experimental autoimmune encephalomyelitis
16. Tumor necrosis factor polymorphisms in multiple sclerosis: No additional association independent of HLA
17. Myelin oligodendrocyte glycoprotein (MOG) gene polymorphism and multiple sclerosis: No evidence of disease association with MOG
18. Genetic control of multiple sclerosis: Increased production of lymphotoxin and tumor necrosis factor-a by HLA-DR2+ T cells
19. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza peptide
20. Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domains of Dr beta 1 chain in multiple sclerosis
21. Structural differences between HLA-DQ molecules associated with myasthenia gravis characterized by molecular modeling
22. HLA-DQB1 codon 57 is critical for peptide binding and recognition
23. Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein
24. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides
25. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein
26. A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus
27. Peptide binding specificity of HLA-DR4 molecules: Correlation with rheumatoid arthritis association
28. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
29. HLA-DRB1*01 subtyping by allele-specific PCR amplification: A sensitive, specific and rapid technique
30. Primers and oligonucleotide probes (SSOP) used for DNA typing of HLA class II alleles
31. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donorrecipient matching in cadaveric transplantations
32. Promiscuous and allele-specific anchors in HLA-DR-binding peptides
33. MHC class-II molecules and autoimmunity
34. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response
35. Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by transgenes encoding modified I-A b-chain or normal I-E a-chain
36. Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in nonobese diabetic mice
37. Prevention of diabetes in nonobese diabetic I-Ak transgenic mice
38. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals
39. MHC control of CD4+ T cell subset activation
40. Major histocompatibility complex (MHC) control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype
41. The major histocompatibility complex influences myelin basic protein 63-88-induced T cell cytokine profile and experimental autoimmune encephalomyelitis
42. Tumor necrosis factor alpha-308 alleles in multiple sclerosis and optic neuritis
43. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone